Edition:
India

Kindred Biosciences Inc (KIN.OQ)

KIN.OQ on NASDAQ Stock Exchange Capital Market

8.85USD
8:10pm IST
Change (% chg)

$0.10 (+1.14%)
Prev Close
$8.75
Open
$8.80
Day's High
$8.85
Day's Low
$8.80
Volume
1,677
Avg. Vol
20,113
52-wk High
$9.80
52-wk Low
$5.00

Chart for

About

Kindred Biosciences, Inc. is a development-stage biopharmaceutical company. The Company is focused on developing therapies for pets. The Company's product pipeline consists of small molecules and biologics for a range of indications in dogs, cats and horses. The Company is developing product candidates for over 20 indications... (more)

Overall

Beta: 0.21
Market Cap(Mil.): $225.49
Shares Outstanding(Mil.): 27.84
Dividend: --
Yield (%): --

Financials

BRIEF-Kindred Biosciences Inc Files For Mixed Shelf Of Up To $150 Million

* KINDRED BIOSCIENCES INC FILES FOR MIXED SHELF OF UP TO $150 MILLION – SEC FILING‍​ Source text - (http://bit.ly/2risHPv) Further company coverage:

18 Jan 2018

BRIEF-KindredBio Announces Submission Of European Medicines Agency Filing For Mirataz

* KINDREDBIO ANNOUNCES SUBMISSION OF EUROPEAN MEDICINES AGENCY FILING FOR MIRATAZ™

21 Dec 2017

BRIEF-KindredBio Announces Positive Results From Pivotal Study Of Zimeta Oral

* KINDREDBIO ANNOUNCES POSITIVE RESULTS FROM PIVOTAL STUDY OF ZIMETA ORAL FOR FEVER IN HORSES

04 Dec 2017

BRIEF-Kindred Biosciences posts Q3 loss of $0.29 per share

* Kindred biosciences announces third quarter 2017 financial results

08 Nov 2017

BRIEF-Kindred Biosciences Q2 loss per share $0.29

* Kindred Biosciences announces second quarter 2017 financial results

08 Aug 2017

Earnings vs. Estimates